DMT-2'-O-Methyladenosine phosphoramidite

Catalog No. :
ACDZAQ460
CAS No. :
138906-75-9
Molecular Formula :
C41H50N7O7P
Molecular Weight :
783.87

IUPAC Name:(2R,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite

DMT-2'-O-Methyladenosine phosphoramidite structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameDMT-2'-O-Methyladenosine phosphoramidite
IUPAC Name(2R,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
Molecular FormulaC41H50N7O7P
Molecular Weight783.87
SMILESCC(N(C(C)C)P(O[C@@H]1[C@@H](COC(C2=CC=C(OC)C=C2)(C3=CC=C(OC)C=C3)C4=CC=CC=C4)O[C@@H](N5C=NC6=C(N)N=CN=C56)[C@@H]1OC)OCCC#N)C
InChI KeyXWBXKGYBWJAXGN-HLHZJIEZSA-N
SynonymAdenosine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite];Adenosine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite;5'-O-dimethoxytritil-2'-O-methyladenosine-3'-O-(2-cianoethyl-N,N-diisopropylphosphoramidite)
CAS No.138906-75-9

Synthetic Route by SureRoute

1. ACDZAQ460 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXACF682 route compound structure diagram
    ACXACF682109-78-4 In Stock
  4. Then
  5. ACDZAQ460 route product structure diagram
    ACDZAQ460138906-75-9
Inquiry

2. ACDZAQ460 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDZAQ460 route product structure diagram
    ACDZAQ460138906-75-9
Inquiry

Comments (0)